TABLE 6

Skeletal-Averaged α-Particle Absorbed Fractions in ICRP Reference Male with Explicit Consideration of Reference Marrow Cellularities (Age, 25 Years)

Energy (MeV)	Target: Trabecular active marrow
Energy (MeV)		φ(TAM←TAM)	φ(TAM←TBE)	φ(TAM←TBE + TAM)	φ(TAM←TBS)	φ(TAM←TBV)
3.0	8.84E−01	1.37E−01	8.55E−01	3.10E−02	4.72E−04
3.5	8.57E−01	1.57E−01	8.29E−01	5.46E−02	1.24E−03
4.0	8.28E−01	1.72E−01	8.03E−01	7.67E−02	2.52E−03
4.5	7.99E−01	1.84E−01	7.76E−01	9.61E−02	4.31E−03
5.0	7.72E−01	1.94E−01	7.50E−01	1.13E−01	6.52E−03
5.5	7.45E−01	2.02E−01	7.25E−01	1.26E−01	9.21E−03
6.0	7.21E−01	2.09E−01	7.02E−01	1.38E−01	1.23E−02
6.5	7.00E−01	2.15E−01	6.82E−01	1.47E−01	1.57E−02
7.0	6.81E−01	2.19E−01	6.64E−01	1.57E−01	1.94E−02
7.5	6.66E−01	2.24E−01	6.50E−01	1.65E−01	2.35E−02
8.0	6.54E−01	2.28E−01	6.39E−01	1.72E−01	2.79E−02
8.5	6.45E−01	2.32E−01	6.30E−01	1.78E−01	3.26E−02
9.0	6.37E−01	2.36E−01	6.22E−01	1.84E−01	3.77E−02
9.5	6.30E−01	2.39E−01	6.17E−01	1.90E−01	4.30E−02
10.0	6.25E−01	2.42E−01	6.12E−01	1.95E−01	4.86E−02

Energy (MeV)	Target: Trabecular bone endosteum
Energy (MeV)		φ(TBE←TAM)	φ(TBE←TBE)	φ(TBE←TBE + TAM)	φ(TBE←TBS)	φ(TBE←TBV)
3.0	1.12E−02	4.75E−01	3.02E−02	4.42E−01	2.26E−02
3.5	1.29E−02	3.99E−01	2.88E−02	3.99E−01	2.75E−02
4.0	1.43E−02	3.41E−01	2.78E−02	3.59E−01	3.20E−02
4.5	1.53E−02	2.97E−01	2.69E−02	3.23E−01	3.63E−02
5.0	1.59E−02	2.61E−01	2.60E−02	2.92E−01	4.02E−02
5.5	1.63E−02	2.31E−01	2.52E−02	2.66E−01	4.40E−02
6.0	1.67E−02	2.07E−01	2.46E−02	2.47E−01	4.76E−02
6.5	1.70E−02	1.88E−01	2.41E−02	2.30E−01	5.08E−02
7.0	1.72E−02	1.72E−01	2.36E−02	2.08E−01	5.40E−02
7.5	1.73E−02	1.58E−01	2.32E−02	1.89E−01	5.65E−02
8.0	1.74E−02	1.45E−01	2.27E−02	1.74E−01	5.89E−02
8.5	1.74E−02	1.34E−01	2.23E−02	1.64E−01	6.11E−02
9.0	1.73E−02	1.26E−01	2.19E−02	1.53E−01	6.33E−02
9.5	1.72E−02	1.17E−01	2.14E−02	1.43E−01	6.50E−02
10.0	1.70E−02	1.09E−01	2.08E−02	1.35E−01	6.67E−02